(Washington University in St. Louis) A unique genetic signature can alert physicians to high-risk breast tumors that are masquerading as low-risk tumors, according to research at Washington University School of Medicine in St.

Louis and collaborating institutions. Although these tumors are apparently estrogen-receptor positive -- meaning they should depend on estrogen to grow -- they don't respond well to anti-estrogen therapy.